🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

3 recruiting trials

for Nodular Basal Cell Carcinoma

A Study to Evaluate the Safety and Efficacy of EscharEx (EX-02) in the Treatment of Basal Cell Carcinoma NCT05157763Phase 1, Phase 23 sites📍 Aventura📍 Brandon📍 Webster MediWound Ltd · Tests: EscharEx 5% (EX-02 formulation) Study of Intralesional FLD-103 in Subjects With Basal Cell Carcinoma (BCC) NCT07670858Phase 19 sites📍 Bowling Green📍 New York📍 Phillip Feldan Therapeutics · Tests: Intralesional FLD-103 Photodynamic Therapy Associated With Sonodynamic Therapy for the Treatment of Nodular Basal Cell Carcinoma NCT07381972Phase 31 site📍 Jaú University of Sao Paulo · Tests: Control Arm (Conventional Therapy), Experimental arm
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy